You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

deep molecular response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CML Trial in Ciudad Autonoma de Buenos Aire (Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment)

Recruiting
  • CML
  • Discontinuing treatment with Tyrosine Kinase Inhibitor after enrolment
  • Ciudad Autonoma de Buenos Aire, Ciudad Autonoma De Buenos Aires, Argentina
    FUNDALEU
Jun 29, 2023

Hepatocellular Carcinoma Trial in Singapore (Surgical Resection, Adjuvant Atezolizumab-Bevacizumab Therapy)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Surgical Resection
  • Adjuvant Atezolizumab-Bevacizumab Therapy
  • Singapore, Singapore
  • +5 more
Aug 23, 2022

Chronic Myeloid Leukemia Trial in Germany (Nilotinib)

Completed
Has Results
  • Chronic Myeloid Leukemia
  • Mannheim, Baden-Wuerttemberg, Germany
  • +69 more
Mar 21, 2022

Leukemia, Chronic Myeloid Trial in Campinas (Pioglitazone, imatinib discontinuation)

Active, not recruiting
  • Leukemia, Chronic Myeloid
  • Campinas, SP, Brazil
    Centro de Hematologia e Hemoterapia - Universidade Estadual de C
Nov 2, 2020

Chronic Myeloid Leukemia, Chronic Myeloid Leukemia in Remission, BCR-ABL Positive Chronic Myelogenous Leukemia Trial in Moscow

Active, not recruiting
  • Chronic Myeloid Leukemia
  • +2 more
  • Moscow, Russian Federation
    National Research Center for Hematology
Oct 1, 2020

Pregnancy Related Trial in Giza (deep breathing exercise inform of diaphragmatic and costal breathing)

Completed
  • Pregnancy Related
  • deep breathing exercise inform of diaphragmatic and costal breathing
  • Giza, Egypt
    Soaad kafafy university hospital
Sep 3, 2023

Outcome in Colorectal Liver Metastases

Completed
  • The Characteristics of Patients With Colorectal Cancer Liver Metastasis Who Would Benefit More From Bevacizumab
  • Deep radiomics-based fusion model
  • Shanghai, China
    Department of General Surgery, Zhongshan Hospital, Fudan Univers
Aug 29, 2023

Atopic Dermatitis Trial in San Francisco (Dupilumab)

Recruiting
  • Atopic Dermatitis
  • San Francisco, California
    University of California, San Francisco
May 4, 2023

Neoadjuvant Chemoimmunotherapy in Non-small Cell Lung Cancer

Recruiting
  • Non-small Cell Lung Cancer
  • +2 more
  • CT/PET/WSI-based Deep Learning Signature
  • Zunyi, Guizhou, China
  • +2 more
Jun 27, 2023

According to Molecular Identification at Diagnosis

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Next Generation Sequencing (DNA and RNA)
  • (no location specified)
Oct 28, 2022

Multimodal Deep Learning Radiomic Nomogram for Evaluation of

Not yet recruiting
  • Colorectal Cancer
  • Liver Metastases
  • Shanghai, Shanghai, China
    Zhongshan hospital
Jan 4, 2023

PD-1 Checkpoint Blockade Using Deep Learning Analysis of Imaging

Completed
  • Non-small Cell Lung Cancer (NSCLC)
    • Nîmes, France
      Jean-Paul BEREGI
    Jan 25, 2023

    Glioma (Diagnosis), Liquid Biopsy, Deep Learning Trial in Wuhan, Nanchang (Prediction of glioma grading and molecular subtype)

    Recruiting
    • Glioma (Diagnosis)
    • +2 more
    • Prediction of glioma grading and molecular subtype
    • Wuhan, Hubei, China
    • +1 more
    Sep 8, 2022

    Neuromuscular Blockade, Innate Inflammatory Response, Quality of Life Trial in Nijmegen (Rocuronium Bromide)

    Recruiting
    • Neuromuscular Blockade
    • +3 more
    • Rocuronium Bromide
    • Nijmegen, Netherlands
      Radboudumc
    Jan 8, 2023

    Leukemia, Chronic Myeloid Trial in Malaysia (Peginterferon-a-2a)

    Active, not recruiting
    • Leukemia, Chronic Myeloid
    • Johor Bahru, Johor, Malaysia
    • +8 more
    Sep 11, 2020

    Chronic Myeloid Leukemia, Chronic Phase, Withdrawal;Drug Trial in Czechia (Imatinib withdrawal, Dasatinib, Nilotinib)

    Recruiting
    • Chronic Myeloid Leukemia, Chronic Phase
    • Withdrawal;Drug
    • Imatinib withdrawal
    • +2 more
    • Brno, Czechia
    • +7 more
    Aug 24, 2022

    CML, Chronic Myelogenous Leukemia, Leukemia, Myeloid Chronic Trial in Worldwide (Asciminib add-on, Imatinib, Nilotinib)

    Recruiting
    • CML
    • +3 more
    • Asciminib add-on
    • +3 more
    • Augusta, Georgia
    • +46 more
    Jan 23, 2023

    Crohn's Disease, Ulcerative Colitis Trial (Samples)

    Not yet recruiting
    • Crohn's Disease
    • Ulcerative Colitis
    • Samples
    • (no location specified)
    Feb 8, 2023

    Athletic Performance, Muscle Fatigue, Oxidative Stress Trial in Olomouc (Hydrogen rich water, Placebo)

    Enrolling by invitation
    • Athletic Performance
    • +2 more
    • Hydrogen rich water
    • Placebo
    • Olomouc, Czechia
      Palacky University, Faculty of Physical Culture
    Apr 11, 2023

    Nilotinib for Chronic Myeloid Leukemia in First Line and Any

    Completed
    • Chronic Myeloid Leukemia
    • Nilotinib
    • Freudenstadt, Baden Wuerttemberg, Germany
    • +76 more
    Feb 9, 2023

    Near Patient Molecular Testing in Sepsis

    Active, not recruiting
    • Sepsis
    • Systemic Inflammatory Response Syndrome
      • Los Angeles, California
      • +2 more
      Jul 19, 2022

      Vital Pulp Therapy Trial in Mansoura (Pulp therapy, Cytokines level in pulpal blood.)

      Completed
      • Vital Pulp Therapy
      • Pulp therapy
      • Cytokines level in pulpal blood.
      • Mansoura, Dakahliya, Egypt
        Mansoura University
      Jul 18, 2022

      Genetic Change Trial in Zhengzhou (Gene evolution and molecular response under Bevacizumab treatment)

      Recruiting
      • Genetic Change
      • Gene evolution and molecular response under Bevacizumab treatment
      • Zhengzhou, Henan, China
        Henan Provincial People's Hospital
      Aug 21, 2022

      Treatment in FH-deficient RCC Patients

      Recruiting
      • FH-Deficient RCC
      • +2 more
      • Laboratory analysis of samples
      • Shanghai, Shanghai, China
        Ethics Committee of Shanghai Renji Hospital
      Sep 6, 2022

      Respiratory Viral Infections in Pediatric Transplant Recipients

      Recruiting
      • Hematopoietic Cell Transplant
      • +2 more
        • Little Rock, Arkansas
        • +4 more
        Jan 11, 2023